Analyst Recommendations

Citigroup analyst issues BUY recommendation for AMAT on February 4, 2026 11:16AM ET. The previous analyst recommendation was Buy.AMAT was trading at $318.67 at issue of the analyst...

February 4, 2026   AMAT -0.04%

Citigroup analyst issues BUY recommendation for TDC on February 4, 2026 11:18AM ET. The previous analyst recommendation was Buy.TDC was trading at $26.03 at issue of the analyst...

February 4, 2026   TDC -1.05%

Wells Fargo analyst issues OVERWEIGHT recommendation for MRK on February 4, 2026 11:16AM ET. The previous analyst recommendation was Overweight.MRK was trading at $115.86 at issue of the...

February 4, 2026   MRK -0.02%

Citigroup analyst issues NEUTRAL recommendation for AMGN on February 4, 2026 11:20AM ET. The previous analyst recommendation was Neutral.AMGN was trading at $338.59 at issue of the analyst...

February 4, 2026   AMGN -0.61%

Wells Fargo analyst issues OVERWEIGHT recommendation for BALL on February 4, 2026 11:26AM ET. The previous analyst recommendation was Overweight.BALL was trading at $61.77 at issue of the...

February 4, 2026   BALL -3.41%

Wells Fargo analyst issues OVERWEIGHT recommendation for WTW on February 4, 2026 11:22AM ET. The previous analyst recommendation was Overweight.WTW was trading at $335.1 at issue of the...

February 4, 2026   WTW 1.49%

Wells Fargo analyst issues OVERWEIGHT recommendation for TTWO on February 4, 2026 11:25AM ET. The previous analyst recommendation was Overweight.TTWO was trading at $212.17 at issue of the...

February 4, 2026   TTWO -0.70%

Wells Fargo analyst issues OVERWEIGHT recommendation for HUBB on February 4, 2026 11:28AM ET. The previous analyst recommendation was Overweight.HUBB was trading at $503.86 at issue of the...

February 4, 2026   HUBB -3.29%

Wells Fargo analyst issues POSITIVE recommendation for EMR on February 4, 2026 11:31AM ET. The previous analyst recommendation was Positive.EMR was trading at $152.1 at issue of the...

February 4, 2026   EMR -1.37%

UBS analyst issues NEUTRAL recommendation for MDLZ on February 4, 2026 11:31AM ET. The previous analyst recommendation was Neutral.MDLZ was trading at $59.47 at issue of the analyst...

February 4, 2026   MDLZ -0.50%